Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096610241> ?p ?o ?g. }
- W3096610241 endingPage "663" @default.
- W3096610241 startingPage "647" @default.
- W3096610241 abstract "Abstract The rapid evolution of novel, costly therapies for neuroendocrine neoplasia (NEN) warrants formal high-quality cost-effectiveness evaluation. Costs of individual investigations and therapies are high; and examples are presented. We aimed to review the last ten years of standalone health economic evaluations in NEN. Comparing to published standards, EMBASE, Cochrane library, Database of Abstracts of Reviews of Effects (DARE), NHS Economic Evaluation Database and the Health Technology Assessment (HTA) Database were searched for health economic evaluations (HEEs) in NEN published between 2010 and October 2019. Of 12 economic evaluations, 11 considered exclusively pharmacological treatment (3 studies of SSAs, 7 studies of sunitinib, everolimus and/or 177Lu-DOTATATE and 1 study of telotristat ethyl) and 1 compared surgery with intraarterial therapy. 7 studies of pharmacological treatment had placebo or best supportive care as the only comparator. There remains a paucity of economic evaluations in NEN with the majority industry funded. Most HEEs reviewed did not meet published health economic criteria used to assess quality. Lack of cost data collected from patient populations remains a significant factor in HEEs where clinical expert opinion is still often substituted. Further research utilizing high-quality effectiveness data and rigorous applied health economic analysis is needed." @default.
- W3096610241 created "2020-11-09" @default.
- W3096610241 creator A5001794233 @default.
- W3096610241 creator A5009110738 @default.
- W3096610241 creator A5027344461 @default.
- W3096610241 creator A5042494371 @default.
- W3096610241 creator A5071268085 @default.
- W3096610241 creator A5085780530 @default.
- W3096610241 date "2020-11-06" @default.
- W3096610241 modified "2023-10-18" @default.
- W3096610241 title "Evaluating cost-effectiveness in the management of neuroendocrine neoplasms" @default.
- W3096610241 cites W1549369569 @default.
- W3096610241 cites W1575433014 @default.
- W3096610241 cites W1803511184 @default.
- W3096610241 cites W1896805399 @default.
- W3096610241 cites W1965366920 @default.
- W3096610241 cites W1992673558 @default.
- W3096610241 cites W2002071982 @default.
- W3096610241 cites W2010344947 @default.
- W3096610241 cites W2014811656 @default.
- W3096610241 cites W2015756811 @default.
- W3096610241 cites W2046207560 @default.
- W3096610241 cites W2060667170 @default.
- W3096610241 cites W2064700601 @default.
- W3096610241 cites W2065170253 @default.
- W3096610241 cites W2079292111 @default.
- W3096610241 cites W2082881701 @default.
- W3096610241 cites W2087340916 @default.
- W3096610241 cites W2115686439 @default.
- W3096610241 cites W2131779687 @default.
- W3096610241 cites W2137142564 @default.
- W3096610241 cites W2139195205 @default.
- W3096610241 cites W2142704172 @default.
- W3096610241 cites W2151765512 @default.
- W3096610241 cites W2158474413 @default.
- W3096610241 cites W2165162853 @default.
- W3096610241 cites W2209368665 @default.
- W3096610241 cites W2257387609 @default.
- W3096610241 cites W2320201751 @default.
- W3096610241 cites W2338555370 @default.
- W3096610241 cites W2547287898 @default.
- W3096610241 cites W2573369749 @default.
- W3096610241 cites W2599795450 @default.
- W3096610241 cites W2608160487 @default.
- W3096610241 cites W2650689221 @default.
- W3096610241 cites W2735046476 @default.
- W3096610241 cites W2747224422 @default.
- W3096610241 cites W2758485836 @default.
- W3096610241 cites W2783806190 @default.
- W3096610241 cites W2789373491 @default.
- W3096610241 cites W2793914041 @default.
- W3096610241 cites W2846786516 @default.
- W3096610241 cites W2889779979 @default.
- W3096610241 cites W2891044561 @default.
- W3096610241 cites W2899817995 @default.
- W3096610241 cites W2901569333 @default.
- W3096610241 cites W2911179395 @default.
- W3096610241 cites W2917124294 @default.
- W3096610241 cites W2946983839 @default.
- W3096610241 cites W2947597672 @default.
- W3096610241 cites W2972837996 @default.
- W3096610241 cites W2981961317 @default.
- W3096610241 cites W2990459105 @default.
- W3096610241 cites W3028430747 @default.
- W3096610241 cites W4210406669 @default.
- W3096610241 doi "https://doi.org/10.1007/s11154-020-09608-y" @default.
- W3096610241 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8346405" @default.
- W3096610241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33155118" @default.
- W3096610241 hasPublicationYear "2020" @default.
- W3096610241 type Work @default.
- W3096610241 sameAs 3096610241 @default.
- W3096610241 citedByCount "2" @default.
- W3096610241 countsByYear W30966102412022 @default.
- W3096610241 crossrefType "journal-article" @default.
- W3096610241 hasAuthorship W3096610241A5001794233 @default.
- W3096610241 hasAuthorship W3096610241A5009110738 @default.
- W3096610241 hasAuthorship W3096610241A5027344461 @default.
- W3096610241 hasAuthorship W3096610241A5042494371 @default.
- W3096610241 hasAuthorship W3096610241A5071268085 @default.
- W3096610241 hasAuthorship W3096610241A5085780530 @default.
- W3096610241 hasBestOaLocation W30966102411 @default.
- W3096610241 hasConcept C112930515 @default.
- W3096610241 hasConcept C121608353 @default.
- W3096610241 hasConcept C126322002 @default.
- W3096610241 hasConcept C142724271 @default.
- W3096610241 hasConcept C160735492 @default.
- W3096610241 hasConcept C162324750 @default.
- W3096610241 hasConcept C17744445 @default.
- W3096610241 hasConcept C177713679 @default.
- W3096610241 hasConcept C199539241 @default.
- W3096610241 hasConcept C2776125615 @default.
- W3096610241 hasConcept C2779473830 @default.
- W3096610241 hasConcept C2779490328 @default.
- W3096610241 hasConcept C3019080777 @default.
- W3096610241 hasConcept C50522688 @default.
- W3096610241 hasConcept C71924100 @default.
- W3096610241 hasConceptScore W3096610241C112930515 @default.
- W3096610241 hasConceptScore W3096610241C121608353 @default.